DCP
BIIB icon

Distillate Capital Partners’s Biogen BIIB Stock Holding History

Distillate Capital Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-28,398
Closed -$5.98M – 111
2022
Q1 		$5.98M Buy
28,398
+10,451
+58% +$2.27M 0.85% 55
2021
Q4 		$4.3M Buy
17,947
+7,648
+74% +$1.97M 0.72% 78
2021
Q3 		$2.91M Sell
10,299
-746
-7% -$245K 0.78% 67
2021
Q2 		$3.83M Sell
11,045
-1,429
-11% -$433K 1.06% 25
2021
Q1 		$3.49M Buy
12,474
+5,031
+68% +$1.36M 1.13% 20
2020
Q4 		$1.81M Buy
+7,443
New +$1.92M 0.87% 48

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Distillate Capital Partners's BIIB Position: Q2 2022 in Review

Distillate Capital Partners sold out of Biogen (BIIB) in Q2 2022, closing a stake of 28,398 shares — an estimated $5.98M sold.

Distillate Capital Partners first reported a position in BIIB in Q4 2020 and held it in 6 quarters. The position peaked at $5.98M in Q1 2022. 927 funds tracked by Wall St. Rank hold BIIB as of Q2 2022.

  • Distillate Capital Partners reported no remaining Biogen position as of Q2 2022 after selling out during the quarter.
  • Distillate Capital Partners sold 28,398 Biogen shares in Q2 2022, an estimated $5.98M.
  • Distillate Capital Partners first reported a position in Biogen in Q4 2020 and held it in 6 quarters.
  • Distillate Capital Partners's Biogen position peaked at $5.98M in Q1 2022.
  • 927 funds tracked by Wall St. Rank held Biogen as of Q2 2022.

Based on Distillate Capital Partners's 13F filing for Q2 2022, filed 3 Aug 2022.